Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study.
Saved in:
| Title: | Immunogenicity and Safety of the ExPEC9V Escherichia coli Vaccine Co-Administered with a High-Dose Influenza Vaccine in Older Adults: A Placebo-Controlled, Randomized, Phase 3 Study. |
|---|---|
| Authors: | Leroux-Roels I; Center for Vaccinology, Ghent University and Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium., Day TA; Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium., Deleu S; Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium., McLean C; Johnson & Johnson, Archimedesweg 4, 2333CN Leiden, The Netherlands., Go O; Johnson & Johnson, 920 US-202, Raritan, NJ 08869, USA., Davies TA; Johnson & Johnson, 920 US-202, Raritan, NJ 08869, USA., Stoop JN; Johnson & Johnson, Archimedesweg 4, 2333CN Leiden, The Netherlands., Peeters M; Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium., Pau MG; Johnson & Johnson, Archimedesweg 4, 2333CN Leiden, The Netherlands., Spiessens B; Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium., Sarnecki M; Johnson & Johnson, Rehhagstrasse 79, 3018 Bern, Switzerland., Cohen KA; Johnson & Johnson, 1125 Bear Tavern Rd, New Brunswick, NJ 08560, USA. |
| Corporate Authors: | E.ngage Study Team |
| Source: | Vaccines [Vaccines (Basel)] 2026 Jan 30; Vol. 14 (2). Date of Electronic Publication: 2026 Jan 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines14020146 |
